Mount Yale Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Mount Yale Investment Advisors's AMGN Position: Q2 2026 in Review
Mount Yale Investment Advisors increased its Amgen (AMGN) stake by 19% in Q2 2026, buying an estimated $1.39M and bringing the position to 25,505 shares worth $9.24M. The position accounts for 0.17% of the portfolio, ranked #136.
Mount Yale Investment Advisors first reported a position in AMGN in Q1 2018 and has held it in 19 quarters since. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Mount Yale Investment Advisors held 25,505 shares of Amgen worth $9.24M as of Q2 2026.
- Mount Yale Investment Advisors bought 4,062 Amgen shares in Q2 2026, an estimated $1.39M.
- Amgen made up 0.17% of Mount Yale Investment Advisors's portfolio in Q2 2026, its #136 holding.
- Mount Yale Investment Advisors first reported a position in Amgen in Q1 2018 and has held it in 19 quarters since.
- 3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Mount Yale Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.